ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 798

Predominant Fasciitis and Mild Intramuscular Edema on Muscle Magnetic Resonance Imaging in Scleroderma-Associated Myopathy

Julie J. Paik1, Shivani Ahlawat2, Filippo DelGrande3, Laura K. Hummers4, Fredrick M. Wigley4, Ami A. Shah4, Andrew Mammen5 and Laura Fayad6, 1Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Johns Hopkins University, Baltimore, MD, 4Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6Radiology, Johns Hopkins University, Baltimore, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Imaging, Scleredema and myopathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Skeletal myopathy in systemic sclerosis is poorly defined. The spectrum of muscle histopathology in systemic sclerosis has been previously studied and shown to be heterogeneous. There has been little data to describe the imaging findings in scleroderma muscle disease. The purpose of this study is to determine whether there are unique muscle magnetic resonance imaging (MRI) features of scleroderma associated myopathy.

Methods:

This retrospective, cross-sectional study included 25 patients with SSc and biopsy proven fibrosing myopathy or inflammatory myopathy as previously described (1). These patients also had coronal and axial T1-weighted images and short tau inversion recovery (STIR images) of the thighs as part of routine clinical care. A small subset (n=15) also had axial diffusion weighted imaging (DWI) using 2 b-values (0 and 800 s/mm2) and apparent diffusion coefficient (ADC) mapping. Two musculoskeletal radiologists, blinded to histopathological finding, reviewed the MR studies in consensus and semi-quantitatively evaluated for the presence of intramuscular edema, fascial edema, fatty replacement and atrophy on all sequences using equidistant 4-point scoring system (0 = absence, 1 = mild, 2 = moderate, 3 = maximal) for 36 individual skeletal muscles in each patient. Pairwise comparisons for categorical variables between the fibrosing and non-fibrosing groups were made using χ2 test.

Results: There were 12 patients with fibrosing myopathy and 13 patients with an inflammatory myopathy with available MRI data. On STIR sequences, patients with a fibrosing myopathy more often had mild intramuscular (48% (170/355) vs. 36% (176/485), p=.0005) but more prominent fascial edema (16% (46/294) vs.9% (47/496), p=.0005) when compared with the inflammatory myopathy group. Whereas, on T1-weighted sequences, patients with an inflammatory myopathy more often had evidence of chronic muscle damage such as mild fatty replacement (36% (182/504) vs. 27% (82/306), p=0.008) and atrophy (44% (217/498) vs. 34% (104/306), p=0.005) when compared with a fibrosing myopathy. On DWI, patients with SSc-associated fibrosing myopathy more often had elevated signal for both low and high b-value images.

Conclusion:

Thigh muscle MRI may be a useful imaging biomarker to distinguish fibrosing myopathy from inflammatory myopathy in systemic sclerosis.

Reference

  1. Paik JJ, Wigley FM, Shah AA, Corse AM, Casciola-Rosen L, Hummers LK, et al. Fibrosing myopathy in systemic sclerosis associates with higher mortality. Arthritis Care Res 2017.

Disclosure: J. J. Paik, None; S. Ahlawat, None; F. DelGrande, None; L. K. Hummers, None; F. M. Wigley, None; A. A. Shah, Bristol-Myers Squibb, 5; A. Mammen, None; L. Fayad, None.

To cite this abstract in AMA style:

Paik JJ, Ahlawat S, DelGrande F, Hummers LK, Wigley FM, Shah AA, Mammen A, Fayad L. Predominant Fasciitis and Mild Intramuscular Edema on Muscle Magnetic Resonance Imaging in Scleroderma-Associated Myopathy [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/predominant-fasciitis-and-mild-intramuscular-edema-on-muscle-magnetic-resonance-imaging-in-scleroderma-associated-myopathy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predominant-fasciitis-and-mild-intramuscular-edema-on-muscle-magnetic-resonance-imaging-in-scleroderma-associated-myopathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology